| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |